Leonardo Furtado Freitas on CADASIL: Early Diagnosis Equals Better Management
Leonardo Furtado Freitas, Clinical Associate Professor of Neuroradiology at Florida International University, shared on LinkedIn:
”Just published!
Our case report on CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy) highlights the critical role of MRI and genetic testing in diagnosing this underrecognized condition.
In this case, a 46-year-old woman presented with progressive gait disturbance, vertigo, and transient sensory symptoms.
MRI revealed hyperintense lesions in the temporal poles and external capsules, plus a lacunar infarct in the gangliocapsular region—classic imaging features of CADASIL!
Radiologists, always keep CADASIL in mind when facing unexplained white matter changes and early-onset strokes.
Early diagnosis equals better management.”
Read the full article here.
Article: Autosomal Dominant Cerebral Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
Authors: Vitor Hugo de Souza, Márcio Luís Duarte, Marcelo de Queiroz Pereira da Silva, Leonardo Furtado Freitas
Stay updated on all scientific advances with Hemostasis Today.
-
May 29, 2026, 04:37Josefin Ahnström: How Andexanet Alfa Impacts TFPIα Function
-
May 29, 2026, 03:19Building Safer Systems for Anticoagulation Management – ISTH
-
May 29, 2026, 03:07Early Diagnosis Can Change the Lives of Women With Haemophilia – EHC
-
May 29, 2026, 02:41Ifeanyichukwu Ifechidere: The Biggest DOAC Myth in Coagulation – ‘No Monitoring Required’
-
May 29, 2026, 02:35Mariam Swidan: Why Is LDH the ‘Tattletale’ of the Lab?
-
May 29, 2026, 02:20Yuntian Wang: Multi-View Learning for Predicting Avatrombopag Response in Pediatric Immune Thrombocytopenia
-
May 29, 2026, 01:57Giuseppina Caligiuri: Pathophysiological Challenges and Emerging Therapeutic Strategies in Acute Stroke
-
May 28, 2026, 23:47Hussnain Javaid: The Importance of Targeted Examination in Iron Deficiency Anaemia
-
May 28, 2026, 23:47ASH Heads to ASCO26 with Career Opportunities and Global Hematology Leadership